Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2020/06/025647
CTRI/2020/06/025647
Not yet recruiting
Phase 3

Comparing platelet inhibition with crushed versus integral pill administration of clopidogrel and ticagrelor in patients with acute coronary syndrome undergoing percutaneous intervention

Fluid Research Fund0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: I22- Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: I22- Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
Sponsor
Fluid Research Fund
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Fluid Research Fund

Eligibility Criteria

Inclusion Criteria

  • •Patients presenting within 12 hours from the onset of symptoms with ACS as per ACC/AHA criteria and undergoing PCI.
  • •Patients giving informed consent obtained in writing.

Exclusion Criteria

  • •Age \< 18 years or Age \> 75 years.
  • •Inability to give informed consent.
  • •Active bleeding; bleeding diathesis; coagulopathy
  • •History of GI, I.C, genitourinary or other site abnormal bleeding \< 3 months
  • •Suspected aortic dissection
  • •Known relevant hematological deviations: Hb \<10 g/dl, Platelets \<50000\.
  • •Known severe liver disease, severe renal failure
  • •Pregnancy/breastfeeding.
  • •Allergy / Hypersensitivity.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
A Study of Acute Coronary Syndrome Patients
CTRI/2010/091/000348Eli Lilly210
Not yet recruiting
Phase 4
The magnitude of platelet inhibition and the pharmacokinetics of a 600 mg loading dose of clopidogrel, in different patient categories (stable angina versus acute-coronary syndromes versus ST-elevated myocardial infarction).patients with a history of a stent thrombosis1003553410011082
NL-OMON33697Cardiology200
Completed
Not Applicable
Inhibitory efficacy in platelet aggregation and pharmacokinetics of single oral administration of 300mg clopidogrel and 20mg prasugrelIschemic heart diseases with PIC
JPRN-UMIN000014161Kazuo Umemura Center for clinical research Hamamatsu University Hospital50
Terminated
Not Applicable
Comparison of the effect of an anti-platelet intervention with Ticagrelor versus placebo on participants with asymptomatic elevations in troponin T
ACTRN12614000189628Professor Derek Chew420
Recruiting
Not Applicable
Effect of platelet rich fibrin on soft tissue thickness
IRCT20200914048713N1Mashhad University of Medical Sciences20